ConductScience.org, home

Comparison · NCT05167734-deaths

Anemia Treatment Bundle vs Control (Standard of Care) Group: deaths from any cause

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Anemia Treatment Bundle vs Control (Standard of Care) Group: deaths from any cause. Trial comparisons, record NCT05167734-deaths. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT05167734-deaths

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.06120.0210.165wilson
Risk in group 20.03920.01080.132wilson
Risk difference, group 1 minus group 20.022-0.07930.13newcombe hybrid score
Risk ratio, group 1 over group 21.560.2728.95log
Odds ratio, group 1 over group 21.60.25510log
Number needed to harm, for one more death from any cause on Anemia Treatment Bundle than on Control (Standard of Care) Group45.4from the risk difference intervalthe interval includes no difference

Groups2

Group 2 names the comparator: standard of care.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Anemia Treatment Bundle
The intervention arm is multi-faceted with 3 primary components: 1) Optimized phlebotomy, defined by minimal volume draws and closed-loop blood sampling, all performed by a dedicated phlebotomy team independent from the treatment team; 2) Decision support aids, including visual and electronic alerts reminding the care team to minimize non-essential laboratory testing and mitigate patient-specific bleeding risk; and 3) Pharmacologic anemia treatment with a single dose of IV iron and/or subcutaneous erythropoietin (given immediately following enrollment) targeted to 2 broad groups: 1) anemias responsive to iron supplementation alone (i.e. acute blood loss, iron deficiency) and 2) anemias requiring erythropoietic stimulation (e.g. anemia of inflammation, anemia of renal disease).~Iron Dextran: 1000 mg IV~Erythropoietin (EPO): 40,000 units subcutaneous
349EG001
Group 2Control (Standard of Care) GroupSubjects received standard clinical care for the treatment of anemia while in the ICU.251EG000

Harm

What it counts
Total, all-cause mortality
Time frame
Adverse events were collected from baseline through approximately 3-months after hospitalization.

Source ClinicalTrials.gov

Trial

Title
Practical Anemia Bundle for SusTained Blood Recovery
NCT number
NCT05167734
Phases
PHASE2
Conditions
Anemia, Critical Illness
Interventions
Iron Dextran, Erythropoietin (EPO)
Lead sponsor
Mayo Clinic
Results first posted
2025-04-06

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT05167734-deaths